Minovia Therapeutics’ Collaboration and License Agreement with Astellas Pharma

Martina Bellini North America, North America Legal Chronicle
Tagged:

Goodwin Procter advised Minovia Therapeutics on the deal.Minovia Therapeutics announced its worldwide strategic collaboration and license agreement with Astellas Pharma (TSE: 4503) to research, develop, and commercialize…

Membership Required

You must be a member to access this content.

View Membership Levels

Already a member? Log in here
  Share:
Martina Bellini

Author: Martina Bellini

…

Membership Required

You must be a member to access this content.

View Membership Levels

Already a member? Log in here